Ribozymes in the Age of Molecular Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|4|5|489-506

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.4, Iss.5, 2004-08, pp. : 489-506

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Deciphering of the ABO System as a Basis for Novel Diagnostics and Therapeutics in ABO Incompatible Transplantation

By Holgersson Jan   Rydberg Lennart   Breimer Michael E.  

International Reviews of Immunology, Vol. 33, Iss. 3, 2014-05 ,pp. : 174-194

Informa Healthcare

Access to resources Recommend Favorite

Reprogramming of Molecular Switching Events in UPR Driven ER Stress: Scope for Development of Anticancer Therapeutics

By  

Current Molecular Medicine, Vol. 16, Iss. 8, 2016-09 ,pp. : 690-701

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro Characterization of Hammerhead Ribozymes Against Perforin and fas-Ligand RNA

By Du Z.   Ricordi C.   Podack E.   Pastori R.L.  

Transplantation Proceedings, Vol. 29, Iss. 4, 1997-06 ,pp. : 2224-2225

Elsevier

Access to resources Recommend Favorite

Immunomodulation in cancer therapeutics

By Ehrke M.J.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1105-1119

Elsevier

Access to resources Recommend Favorite

Telomerase Therapeutics for Degenerative Diseases

By  

Current Molecular Medicine, Vol. 5, Iss. 2, 2005-03 ,pp. : 205-211

Bentham Science Publishers

Access to resources Recommend Favorite